SMAD6 and craniosynostosis: From that point of view, the fact that a limited portion of human subjects with the SNPs in the putative enhancer region of BMP2 develops CFA while all patients who also have mutations in a SMAD6 exon develop craniosynostosis eloquently demonstrate small increase of BMP signaling is critically involved in etiology of CFAs in human.